What are the indications for Regorafenib?

Regorafenib (Regorafenib) is an oral multi-target targeted therapy used to treat certain types of cancer. It mainly acts on various signaling pathways within tumor cells to inhibit the growth and spread of tumors. The following are the indications and related information for regorafenib :

1.Liver cancer (primary hepatocellular carcinoma):Regofenib (regorafenib) is approved for the treatment of advanced liver cancer, especially in patients who cannot be surgically removed or are not suitable for other treatments. For patients with advanced liver cancer, regorafenib (regorafenib) can be used as a first-line treatment or alternative treatment option.

2.Colorectal Cancer: Regorafenib is also approved to treat metastatic colorectal cancer, particularly in patients who have progressed despite treatment. For these patients, regorafenib can be used as a later-line treatment option to extend survival and reduce symptoms.

3.Gastrointestinal stromal tumor (GIST): Regorafenib (regorafenib) has also shown a certain effect in the treatment of metastatic gastrointestinal stromal tumor. It may be used as an alternative treatment option in patients who are refractory to or intolerant to other treatments.

4.Gastrointestinal tumors with liver metastasis: In addition to treating primary hepatocellular carcinoma, Regorafenib (regorafenib) can also be used to treat colorectal cancer and gastric cancer with liver metastasis. For these patients, regorafenib can slow tumor growth and prolong patient survival.

5.Applicable to undifferentiated glioblastoma (GBM): Recent research suggests that regorafenib may have some therapeutic potential for a rare type of brain tumor called anaplastic glioblastoma. GBMis usually insensitive to traditional chemoradiotherapy, and regorafenib (regorafenib)’s multi-target effect may provide a new direction for treatment.

In general,Regofenib is a multi-target targeted therapy drug suitable for the treatment of various cancers. Although it does not cure cancer, it can extend patients' survival and improve their quality of life. However, the use of regorafenib requires close monitoring of the patient's condition and side effects and adjustments to the treatment regimen based on the individual circumstances.